FDA panel backs gene therapy from Philly’s Spark Therapeutics – whyy
whyy |
FDA panel backs gene therapy from Philly's Spark Therapeutics
whyy A new gene therapy to treat a rare eye condition that can leave children blind has been recommended for approval by a Food and Drug Administration committee. The therapy from Spark Therapeutics, a Philadelphia-based company, could represent an … |
